ANRS, Emerging Infectious Diseases: all 215 studies

Page 1 of 3. Open to participants first (38), then studies with results posted, then the rest; newest registration first within each.

• Immunotherapy With Glatiramer Acetate in PLWHIV in Poor Immunological Responders on Antiretroviral TherapyNot yet recruitingNCT07851337Phase 2
• Detection of Specific Metabolic Signatures by Nuclear Magnetic Resonance or Metabolomic NMR in Correlation With Markers of Inflammation or Immune Activation and the Risk of Developing Neurocognitive Disorders - Longitudinal Retrospective Study Nested in the ANRS12225 PEDIACAM III CohortNot yet recruitingNCT07770568
• Intestinal Tissue-Resident Memory T Cells and HIV-1 Persistence During Antiretroviral TherapyNot yet recruitingNCT07656077Not applicable
• An Experimental Medicine Multicenter Trial to Evaluate the Safety and Immunogenicity of Experimental Versus Authorized SARS-CoV-2 Vaccine Candidates as a Booster Dose in Healthy Participants Previously Vaccinated With Authorized mRNA SARS-CoV-2 Vaccines.RecruitingNCT07605520Early Phase 1
• Assessment of Immune Memory - Humoral and Cellular - in mPOX-infected Patients : an Ancillary Study of the ANRS0258s MOSAIC CohortNot yet recruitingNCT07592429Not applicable
• "Pregnancy and Viral Infections: Impact on Pregnant Women and Their Children. French Prospective Cohort"Not yet recruitingNCT07412977
• Frailty, Geriatric Syndromes and Care Pathways of Older Adults Living With HIV in West AfricaRecruitingNCT07355413
• Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 DiagnosisNot yet recruitingNCT07146529
• Access to Hepatitis C Treatment in Cameroon: Comparison of a Simplified Test and Treat Strategy to a Standard StrategyNot yet recruitingNCT07098481Phase 4
• Immunotherapy With Baricitinib and Sirolimus, Alone and in Combination, for the Control of HIV-1 Replication After Antiretroviral Treatment InterruptionNot yet recruitingNCT07081763Phase 2
• "HBV unIversal vs Point-Of-Care-based Antiviral treatMent to Prevent Mother-to-child Transmission"RecruitingNCT07054359Not applicable
• HIV-1 Non-group M in Cameroon : Study of Genotypic and Phylogenetic Diversity (OBSOCAM)Not yet recruitingNCT06913959
• Prospective Cohort of People Starting Treatment for Tuberculosis Disease in France (FrenchTB)RecruitingNCT06893757
• Prevalence of Drug-resistant Hiv-1 Strains in Patients Experiencing Virologic Failure. (MULTIVIR2025)Not yet recruitingNCT06842706
• EBOla Post-Exposure ProphylaxisNot yet recruitingNCT06841614Phase 3
• Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy AdultsRecruitingNCT06821126Phase 1/2
• Diagnostics and Surveillance of Acute Meningo-encephalitis Among Children in Cambodia With a Focus on Japanese Encephalitis VirusNot yet recruitingNCT06674837
• Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of High-grade Lesions and/or Anal Cancer 10 Years After Inclusion in the ANRS IPERGAY TrialRecruitingNCT06522256Not applicable
• Assisted Notification of Partners of Men Having Sex With Men Discovering Their SeropositivityNot yet recruitingNCT06419491Not applicable
• Study Evaluating the Safety, in Terms of HBV Virological Control At 96 Weeks, of 2 Antiviral Treatment Relief Strategies, in Patients Co-infected with the HIV-1 and HBV VirusesNot yet recruitingNCT06338826Phase 2
• Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France.Not yet recruitingNCT06273943Phase 3
• Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine, Adjuvanted or Not, as a Booster in Volunteers.RecruitingNCT06255626Phase 1/2
• DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 InfectionRecruitingNCT06203132Phase 3
• Seroprevalence of Monkeypox Infection Among People Living With HIV and PrEP UsersNot yet recruitingNCT05922735
• Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France.RecruitingNCT05813964Phase 3
• Pilot Implementation of HIV Self-testing Delivery in Private Pharmacies Combined to a Respondent Driven Sampling Method to Improve HIV Testing for MSM and TGW in Phnom Penh - ANRS 0100sNot yet recruitingNCT05745168
• DRug Use & Infections in ViEtnam: TuBerculosis ControlRecruitingNCT05655702Not applicable
• Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitisRecruitingNCT05590455Phase 2
• OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy TrialRecruitingNCT05587894Phase 2
• Assessment of HIV Remission Upon cART Interruption in Early Treated Individuals Carrying the MHC B35/53Bw4TTC2 GenotypeRecruitingNCT05482854Not applicable
• Immunity to Yellow Fever in HIV-infected Patients 10 Years After a Primary Anti-yellow Fever VaccinationNot yet recruitingNCT05450770Not applicable
• Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART ControlRecruitingNCT05300035Phase 2
• A Study to Determine the Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Bictégravir, Emtricitabine and Ténofovir AlafénamideNot yet recruitingNCT05222945Not applicable
• Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy VolunteersNot yet recruitingNCT05202288Phase 2
• National Cohort of Patients Co-infected with Hepatitis B and Delta VirusesRecruitingNCT04166266
• Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous MeningitisRecruitingNCT04145258Phase 3
• Primary Infection CohortRecruitingNCT03148964
• the ANRS CO21 " Extreme " Cohort (CODEX)RecruitingNCT01520844Not applicable
• Feasibility of Interventions on People Who Inject Drugs in VietnamCompletedNCT02573948Results posted
• Capacity of the Dual Combination Raltegravir/Etravirine to Maintain Virological Success in HIV-1 Infected Patients of at Least 45 Years of Age- ANRS 163 ETRALCompletedNCT02212379Phase 2Results posted
• Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates in Healthy VolunteersCompletedNCT02038842Phase 1/2Results posted
• Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected PatientsCompletedNCT01605890Phase 2Results posted
• Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)CompletedNCT00928187Phase 3Results posted
• Dose Escalation Trial of CD40.Pan.CoV Vaccine, Adjuvanted or Not, as a Booster in Adult Healthy VolunteersActive, not recruitingNCT07113106Phase 1/2
• Negative Serology by Immunoenzymatic Test (EIA) in HIV-infected Children Treated Early With Antiretroviral in the ANRS-Pediacam Study: Pathophysiological MechanismsStatus unknownNCT06302933Not applicable
• Implementation and Effectiveness of Physical Activity to Prevent Disability in HIV-infected Adults Older Than 50 From Côte d'IvoireActive, not recruitingNCT06139497Not applicable
• ANRS0268s POSTCOVIETCompletedNCT06022211
• Study of DAA Treatment for Children and Adolescents With Active HCV Infection in CambodiaActive, not recruitingNCT05992077Not applicable
• HPV Infection, Sexually Transmitted Infections and Anal Dysplasia in the Transgender PopulationCompletedNCT05981807
• Drug Use & Infections in ViEtnam: Mental Health Intervention for INjecting Drug UsersCompletedNCT05886504Not applicable
• Community Intervention to Eliminate HCV Among People Who Use Drugs.Active, not recruitingNCT05794646Not applicable
• Assessment of the Efficacy and Safety of Tecovirimat in Patients With Monkeypox Virus DiseaseActive, not recruitingNCT05597735Phase 3
• Measure of Vaccine Effectiveness to Prevent Hospitalizations for Viral Respiratory Infections in AdultsStatus unknownNCT05582239
• Health and Migration Trajectories of Housekeepers in BamakoCompletedNCT05472051
• Evaluation of the Immunogenicity and Safety BBIBP-CorV Vaccine for COVID-19 in Adults in GuineaActive, not recruitingNCT05409300Phase 2
• Evaluation of the Immunogenicity and Safety of Ad26.COV2.S's COVID-19 VaccineActive, not recruitingNCT05409261Phase 2
• Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokombéré, Cameroon in Pregnant WomenActive, not recruitingNCT05403047Phase 4
• Aging With HIV and Neurocognitive Decline, a Follow-up StudyCompletedNCT05385588Not applicable
• Large Scale Transition to a Dolutegravir-based First-line ART in the South: Virological Response and Impact on HIV Drug Resistance in a Real Life Context (DoReaL Study)CompletedNCT05312918
• Variants of SARS-CoV-2 Causing COVID-19 in AfricaCompletedNCT05311891
• Transmission of Covid-19 During Clubbing Events in Closed PlacesCompletedNCT05311865Not applicable
• Expectation, Motivation and Experience of HIV-patients Regarding Participation to an HIV Cure-related Clinical TrialTerminatedNCT05280392
• Evaluation of the Safety and the Tolerability of a Combination of Two HIV Inducers in Patients With Undetectable Viral LoadCompletedNCT05230368Phase 1
• Pre-exposure Prophylaxis of SARS-CoV-2 Infection (COVID-19) by Monoclonal Antibodies with Early Access Authorization in Immunocompromised Patients. a Prospective Cohort.CompletedNCT05216588
• ANRS HB07 IP-Cure-B Proof of Concept (PoC) Clinical Trial. Educating the Liver Immune Environment Through TLR8 Stimulation Followed by NUC DiscontinuationStatus unknownNCT05045261Phase 2
• Prevention of Mental Health Problems Among Persons Without Personal Housing in the Context of the COVID-19 EpidemicStatus unknownNCT05033210Not applicable
• Evaluation of Measurement of Maternal Viral Load at Delivery to Optimise Post-natal Prophylaxis of HIV-exposed NewbornsCompletedNCT05017558
• Partner Notification of Sexually Transmitted Infections (STIs) in Testing CentersStatus unknownNCT04921618
• Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 InfectionStatus unknownNCT04920838Phase 2/3
• Prevalence and Longitudinal Follow-up of Anal Lesions, HPV Infection and Associated Sexually Transmitted Infections Among Men Who Have Sex With Men in Togo.Status unknownNCT04910438
• Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.CompletedNCT04885452
• Protective Measures Against SARS-CoV-2 Contamination of Young Healthy Volunteers During a Concert of Actual MusicWithdrawnNCT04868942Not applicable
• Dual Therapy in HIV Patients in 4 Days a Week Versus 7 Days a WeekStatus unknownNCT04867083Phase 3
• Severity of the New UK SARS-Cov2 Variant in COVID-19 InfectionStatus unknownNCT04863547
• National Survey About Trajectory and Life Conditions of HIV Trans People in FranceCompletedNCT04849767
• A Prophylactic HIV Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DREP Alone and in Combination With a Clade C ENV Protein in Healthy HIV-uninfected AdultsCompletedNCT04844775Phase 1
• Dose Escalation Trial of CD40.HIVRI.Env Vaccine Combined or Not With a DNA-HIV-PT123 HIV-1 Vaccine in Healthy VolunteersCompletedNCT04842682Phase 1
• Covid-19 Vaccine Cohort in Specific PopulationsCompletedNCT04824651
• BNT162b2 Vaccination With 2 Doses in COVID-19 Negative Volunteers and With a Single Dose in COVID-19 Positive VolunteersCompletedNCT04824638Phase 2
• Prophylaxis Vaccine Antibodies EbolaStatus unknownNCT04822376Phase 2
• Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune SuppressionCompletedNCT04738812Phase 3
• Epidemiological Investigation of COVID-19 in Laos Using a One-Health Approach in Human and AnimalsStatus unknownNCT04716543
• HIV Acquisition and Life Course of Born-abroad Men Who Have Sex With Men Living in Ile-de-France: the GANYMEDE StudyCompletedNCT04684758
• Cohorte Nationale VIH-2Status unknownNCT04658329
• Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/ Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP)CompletedNCT04597424Phase 3
• ANRS 12406 EvvA StudyStatus unknownNCT04593979
• ANRS 12392 Sanu GundoStatus unknownNCT04482010Not applicable
• Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb TrialCompletedNCT04466241Phase 2/3
• HUSH Restriction in HIV Infected PatientsStatus unknownNCT04172480
• Cross Sectional Survey on the Burden, Impacts and Causes of Hepatitis C Virus (HCV) Outbreak in South West Region in Burkina FasoStatus unknownNCT04136405
• Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors BackboneCompletedNCT04133012Not applicable
• A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)CompletedNCT04120415Phase 2
• Reducing Antiretroviral TreatmentsTerminatedNCT04051970Phase 3
• HIV and HCV Infections in 2 Communes From the Battambang Province, Cambodia: Prevalence Rates, Viral Strains, and Unsafe Injection Practices (12352 ANRS ROK INVEST)Status unknownNCT04044586
• ANRS 12372 MODERATO StudyCompletedNCT04022967Phase 3
• Lowering InterLeukin-1 Receptor Antagonist Concentrations After TB Treatment OnsetStatus unknownNCT04015713
• A Community-based Intervention Among Active Drug Users in MontpellierCompletedNCT04008927Not applicable
• Community Versus Facility-based Services to Improve the Screening of Active HCV Infection in CambodiaCompletedNCT03992313Not applicable
• Sexual and Reproductive Health (Including PrEP and HBV) for Female Sex Workers in Côte d'IvoireStatus unknownNCT03985085Not applicable
• Frailty in People Living With HIV Aged 70 Years or MoreStatus unknownNCT03958786Not applicable

← ANRS, Emerging Infectious Diseases overview and focus areas